Galileo - Biotech Innovation Fund IM Fonds
143,26
USD
-4,36
USD
-2,95
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Krystal Biotech Inc | US5011471027 | 8,08% |
| Arrowhead Pharmaceuticals Inc | US04280A1007 | 6,93% |
| Stoke Therapeutics Inc | US86150R1077 | 6,87% |
| Taysha Gene Therapies Inc Ordinary Shares | US8776191061 | 6,35% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,18% |
| Kyverna Therapeutics Inc | US5019761049 | 3,98% |
| 4D Molecular Therapeutics Inc Ordinary Shares | US35104E1001 | 3,87% |
| Moderna Inc | US60770K1079 | 3,81% |
| uniQure NV | NL0010696654 | 3,77% |
| Gilead Sciences Inc | US3755581036 | 3,25% |
| Sonstige | 48,93% |